Table 3. Drugs used in the treatments of all patients and patients with a baseline eGFR<60 and ⩾60 mL/min/1.73 m2.
| Drug | All patients (n = 336) | Patients with baseline eGFR<60 mL/min/1.73 m2 (n = 61) | Patients with baseline eGFR⩾60 mL/min/1.73 m2 (n = 275) | p |
|---|---|---|---|---|
| Hydroxychloroquine | 332 (98.8) | 59 (96.7) | 273 (99.3) | 0.152 |
| Oseltamivir | 285 (84.8) | 48 (78.7) | 237 (86.2) | 0.166 |
| Azithromycin | 294 (87.5) | 51 (83.6) | 243 88.4) | 0.292 |
| Favipiravir | 169 (50.2) | 41 (67.2) | 128 (46.5) | 0.004 |
| Lopinavir/ritonavir | 27 (8.0) | 6 (9.8) | 21 (7.6) | 0.421 |
| Tocilizumab | 57 (17.8) | 9 (14.8) | 48 (17.5) | 0.708 |
| LWMH | 192 (57.3) | 40 (65.6) | 152 (55.3) | 0.115 |
| Glucocorticoid | 21 (6.3) | 2 (3.3) | 19 (6.9) | 0.390 |
eGFR: estimated glomerular filtration rate, LMWH: low-molecular-weight heparin.
Data are expressed as n (%).